TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 23 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $296,000 | -89.3% | 67,567 | -83.0% | 0.01% | -89.8% |
| Q1 2016 | $2,776,000 | -38.0% | 397,085 | -18.1% | 0.12% | -35.2% |
| Q4 2015 | $4,481,000 | -5.4% | 485,000 | 0.0% | 0.18% | -0.5% |
| Q3 2015 | $4,738,000 | -13.8% | 485,000 | 0.0% | 0.18% | 0.0% |
| Q2 2015 | $5,495,000 | -19.3% | 485,000 | 0.0% | 0.18% | -17.2% |
| Q1 2015 | $6,809,000 | – | 485,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALL STREET ASSOCIATES | 241,536 | $1,184,000 | 0.78% |
| NEA Management Company, LLC | 2,759,217 | $13,520,000 | 0.54% |
| Eventide Asset Management | 865,526 | $4,241,000 | 0.28% |
| AWM Investment Company, Inc. | 224,153 | $1,098,000 | 0.22% |
| Kinsight, LLC | 21,318 | $104,000 | 0.05% |
| QVT Financial LP | 381,477 | $1,711,000 | 0.05% |
| NEXTHERA CAPITAL LP | 12,714 | $62,000 | 0.04% |
| Perceptive Advisors | 100,000 | $490,000 | 0.04% |
| TFS CAPITAL LLC | 16,753 | $82,000 | 0.02% |
| Candriam S.C.A. | 143,000 | $701,000 | 0.02% |